tryptophan has been researched along with Hyperparathyroidism, Secondary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goto, M; Horii, Y; Iwai, R; Murakami, S; Nishimura, G; Sato, H; Takahashi, N | 1 |
1 other study(ies) available for tryptophan and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Upacicalcet Is a Novel Secondary Hyperparathyroidism Drug that Targets the Amino Acid Binding Site of Calcium-Sensing Receptor .
Topics: Binding Sites; Humans; Hyperparathyroidism, Secondary; Inositol; Parathyroid Hormone; Propionates; Receptors, Calcium-Sensing; Tryptophan | 2022 |